'Toll-like Receptors from the Perspective of Cancer Treatment' are critical to cancer control, yet accumulated evidence shows that mRNA technology based gene injections subverts immune system's TLRs

by Paul Alexander

When TLRs are ramped up and activated, they function to suppress and prevent tumors from forming and growing. Hyperactivation or hypoactivation of TLRs dysregulates & subverts the anti-tumor role


‘TLR activation in immune as well as cancer cells may prevent the formation and growth of a tumor. Nonetheless, under certain conditions, either hyperactivation or hypoactivation of TLRs supports the survival and metastasis of a tumor.’